Get the Stockscreener App
1.53
13.56%
-0.24
After Hours:
1.53
Mustang Bio Inc stock is traded at $1.53, with a volume of 223.73K.
It is down -13.56% in the last 24 hours and up +8.51% over the past month.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$1.77
Open:
$1.77
24h Volume:
223.73K
Relative Volume:
0.90
Market Cap:
$9.78M
Revenue:
-
Net Income/Loss:
$-23.42M
P/E Ratio:
-0.0196
EPS:
-78
Net Cash Flow:
$-16.67M
1W Performance:
-3.16%
1M Performance:
+8.51%
6M Performance:
+14.18%
1Y Performance:
-86.09%
1-Day Range:
$1.53
$1.81
1-Week Range:
$1.53
$1.85
52-Week Range:
$0.8926
$21.95
Mustang Bio Inc Stock (MBIO) Company Profile
Name
Mustang Bio Inc
Sector
Industry
Phone
(781) 652-4500
Address
377 PLANTATION STREET, WORCESTER, NY
Compare MBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
1.53 | 12.81M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Oct-02-20 | Initiated | B. Riley FBR | Buy |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-19 | Initiated | H.C. Wainwright | Buy |
| Jun-21-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Initiated | Oppenheimer | Outperform |
View All
Mustang Bio Inc Stock (MBIO) Latest News
Can a trend reversal in Mustang Bio Inc. lead to recoveryMarket Weekly Review & Accurate Technical Buy Alerts - newser.com
Candlestick signals on Mustang Bio Inc. stock todayRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Can momentum traders help lift Mustang Bio Inc.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
What drives Mustang Bio Inc stock priceOptions Trading Strategies & Outstanding Investment Portfolio - earlytimes.in
How buybacks impact Mustang Bio Inc. stock valueQuarterly Profit Review & Consistent Income Trade Ideas - newser.com
Can Mustang Bio Inc. hit a new high this monthEarnings Summary Report & Daily Stock Momentum Reports - newser.com
Advanced analytics toolkit walkthrough for Mustang Bio Inc.2025 Short Interest & Daily Volume Surge Trade Alerts - newser.com
Using Python tools to backtest Mustang Bio Inc. strategiesWeekly Loss Report & Verified Stock Trade Ideas - newser.com
Mustang Bio Inc. stock outlook for YEARQuarterly Trade Review & Reliable Entry Point Alerts - newser.com
Is Mustang Bio Inc. meeting your algorithmic filter criteriaJuly 2025 Review & Real-Time Chart Breakout Alerts - newser.com
Mustang Bio Inc. recovery potential after sell offDividend Hike & Safe Capital Growth Tips - newser.com
How sentiment analysis helps forecast Mustang Bio Inc.Chart Signals & Verified Technical Signals - newser.com
How Mustang Bio Inc. stock performs in interest rate cyclesPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Short interest data insights for Mustang Bio Inc.Chart Signals & Stepwise Swing Trade Plans - newser.com
Applying Wyckoff theory to Mustang Bio Inc. stockPortfolio Performance Summary & Fast Moving Trade Plans - newser.com
Price momentum metrics for Mustang Bio Inc. explainedQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com
What risks investors should watch in Mustang Bio Inc. stockJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Mustang Bio Inc Stock (MBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):